• Corpus ID: 36614765

A pilot study to explore the role of a low-carbohydrate intervention to improve GGT levels and HbA 1 c

  title={A pilot study to explore the role of a low-carbohydrate intervention to improve GGT levels and HbA 1 c},
  author={David J Unwin and Daniel J. Cuthbertson and Richard D. Feinman and Victoria S. Sprung},
See page 108 for author information. Excess dietary glucose is believed to lead to insulin resistance, type 2 diabetes and also progressive hepatocyte triglyceride accumulation (non-alcoholic fatty liver disease [NAFLD]). Considering the increased cardiovascular risks associated with NAFLD and type 2 diabetes, effective risk factor management of individuals with these conditions is critical. Weight loss can improve abnormal liver biochemistry, the histological progression of NAFLD and diabetes… 

Figures and Tables from this paper

Low-carbohydrate diet in diabetes mellitus treatment.

The low carbohydrate diet is not recognized in Czech diabetology, and concerns remain particularly about its safety, so this article aims to initiate a discussion about its use as one of the options for dietary treatment of diabetics.

Direct access lifestyle training improves liver biochemistry and causes weight loss but uptake is suboptimal in patients with non-alcoholic fatty liver disease

This study presents first of its kind evaluation of a service collaboration in the UK, where only 1 in 10 patients offered the opportunity completed the programme, a limitation that could affect future strategies.

Low Carbohydrate Lifestyle Reduces Significantly Insulin Need in Type 2 Diabetes Patients

A low carbohydrate dietary lifestyle is effective in improving HbA1c and weight loss and leads to a significant reduction of insulin need.

Low Carbohydrate Dietary Approaches for People With Type 2 Diabetes—A Narrative Review

There is a strong physiological rationale supporting the role of carbohydrate restriction for the management of Type 2 diabetes, and available evidence suggests that low carbohydrate dietary approaches (LCDs) are as effective as, or superior to, other dietary approaches for its management.

Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations

The high confidence in causal associations for incident T2D is sufficient to consider inclusion of GI and GL in food and nutrient-based recommendations, and the cost–benefit analysis suggests food and nutrition advice favors lower GI or GL and would produce significant potential cost savings in national healthcare budgets.

Continuous Glucose Monitoring With Low-Carbohydrate Nutritional Coaching to Improve Type 2 Diabetes Control: Randomized Quality Improvement Program

Among patients with suboptimally controlled T2DM, a combined approach that includes continuous glucose monitoring and low-carbohydrate nutrition counseling can improve glycemic control compared with the standard of care.

Very low-carbohydrate diets in the management of diabetes revisited.

Some of the evidence for very low-carbohydrate diets in diabetes management is introduced and some of the common objections to their use are discussed.

Outcomes of a Digitally Delivered Low-Carbohydrate Type 2 Diabetes Self-Management Program: 1-Year Results of a Single-Arm Longitudinal Study

Overall, glycemic control and weight loss improved, especially for participants who completed all 10 modules of the Low-Carb Program, an online program that teaches a carbohydrate-reduced diet to adults with type 2 diabetes can be effective for gly glucose control, weight loss, and reducing hypoglycemic medications.

Whether one burns fat, and not the type of fat one eats, is the important thing in type 2 diabetes

The effects of omega-3, omega-6, and total dietary polyunsaturated fat on the prevention and treatment of type 2 diabetes are investigated.



Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction.

Two weeks of dietary intervention reduced hepatic triglycerides by ≈42% in subjects with NAFLD; however, reductions were significantly greater with dietary carbohydrate restriction than with calorie restriction.

Aminotransferase and gamma-glutamyl transpeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome

It is concluded that in obesity insulin resistance is a risk factor for raised liver enzyme levels, possibly related to NAFLD.

Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition

Altering the diet composition could be a patient-empowering method of improving the hyperglycemia of type 2 diabetes without weight loss or pharmacologic intervention.

Low carbohydrate diet to achieve weight loss and improve HbA1c in type 2 diabetes and pre‐diabetes: experience from one general practice

The current pilot study explores the results of a low carbohydrate diet for a case series of 19 type 2 diabetes and pre‐diabetes patients over an eight‐month period in a suburban general practice.

The effect of low carbohydrate on energy metabolism

A rapid initial weight loss occurs with a low- carbohydrate diet due to a suppressed appetite, and there is as yet no indication of an increased metabolic rate and an increased thermogenesis by the low-carbohydrate diet.

Low-carbohydrate diet in type 2 diabetes: stable improvement of bodyweight and glycemic control during 44 months follow-up

Advice to obese patients with type 2 diabetes to follow a 20% carbohydrate diet with some caloric restriction has lasting effects on bodyweight and glycemic control.

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

Weight loss is safe, and improves liver histology and cardio-metabolic profile, and for patients not responding to lifestyle intervention, pioglitazone improves histological disease activity, slows fibrosis progression and extensively ameliorates cardio- Metabolic endpoints.

Prospective study of serum gamma-glutamyltransferase and risk of NIDDM.

Findings suggest that a raised serum GGT level is an independent risk factor for NIDDM, and may be a simple and reliable marker of visceral and hepatic fat and, by inference, of hepatic insulin resistance.

How big a problem is non-alcoholic fatty liver disease?

Much of the population is at risk of NAFLD through being overweight or insulin resistant, or both, but how best to identify patients withNAFLD remains unclear, especially in patients with NASH, who are at greatest risk of liver related complications.